Skip to content

THE PREVALENCE OF FUNGAL INFECTIONS IN PATIENTS WITH OBESITY, HIGH BLOOD SUGAR LEVELS , ABNORMAL LIPID PROFILE AND RAISED BLOOD PRESSURE

Metabolic Syndrome among patients having Dermatophytosis- A Hospital based study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084521
Enrollment
180
Registered
2025-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Control Intervention1: METABOLIC SYNDROME AMONG NORMAL POPULATION: INCIDENCE OF METABOLIC SYNDROME AMONG HEALTHY CONTROLS Control Intervention2: Metabolic Syndrome among patients having Dermatophytose

Sponsors

SRMS Medical College
Lead Sponsor
Shailaja Rathi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: AGE MORE THAN 18 YEARS. PATIENT WILLING TO GIVE WRITTEN INFORMED CONSENT. CLINICALLY DIAGNOSED CASE OF DERMATOPHYTOSIS, CONFIRMED WITH KOH SMEAR.

Exclusion criteria

Exclusion criteria: Patient suffering from any chronic systemic disease or cutaneous disorder. Patient on Systemic Corticosteroids, Immunosuppressants, Lipid lowering agents, Anti-Hypertensive Drugs, Antidiabetic Medications ETC. Pregnant or lactating patient. SMOKERS OR ALCOHOLICS.

Design outcomes

Primary

MeasureTime frame
PATIENT HAVING METABOLIC SYNDROME HAS ARE INFECTED MORE BY DERMATOPHYTES FOR CHRONIC PERIOD OF TIME.Timepoint: MORE THAN 6 MONTHS

Secondary

MeasureTime frame
PATIENTS HAVING METABOLIC SYNDROME IS SAME IN NORMAL HEALTHY POPULATION AS COMPARED TO CASESTimepoint: UNSPECIFIED

Countries

India

Contacts

Public ContactShaialja Rathi

Shri Ram Murti Smarak Institute of Medical Sciences

drpratikg@rediffmail.com9319758004

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026